Mild thalassemia refers to a mild form of thalassemia. Low hemoglobin caused by mild thalassemia can be observed for a while if the decline in the index is not obvious, but if the index declines progressively, it can be targeted for treatment.
Mild thalassemia can be improved by paying attention to rest and supplementing nutrients such as folic acid and vitamin E. If necessary, blood transfusion, iron removal therapy (Deferasirox), gene therapy, and splenectomy can be chosen as treatments, and the symptoms of most patients can be relieved or alleviated after active treatment.
Thalassemia, also known as dysgenerative anemia, is a hereditary hemolytic disorder caused by partial or total deficiency (synthetic disorder) of one or more of the normal peptide chains of the pearl proteins. The low hemoglobin caused by thalassemia minor is primarily due to a disorder in the synthesis of the bead protein chain, which is unable to synthesize hemoglobin efficiently.
When diagnosed with thalassemia minor, patients should choose an appropriate treatment plan under the guidance of a doctor to prevent the condition from worsening.